Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer

Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer

Chronic obstructive pulmonary disease (COPD) is associated with a poor prognosis in patients with non-small cell lung cancer (NSCLC). However, the impact of COPD treatment on the survival of patients with advanced NSCLC remains uncertain. We retrospectively investigated COPD patients among patients...

Full description

Bibliographic Details
Main Authors:	Hyunji Jo, Sojung Park, Nam Eun Kim, So Young Park, Yon Ju Ryu, Jung Hyun Chang, Jin Hwa Lee
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Journal of Clinical Medicine
Subjects:	bronchodilator chronic obstructive pulmonary disease inhaled corticosteroids non-small cell lung cancer survival
Online Access:	https://www.mdpi.com/2077-0383/11/9/2391

Similar Items

Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
by: Sun Hye Shin, et al.
Published: (2020-08-01)

Pharmacological therapy for stable chronic obstructive pulmonary disease
by: Ruirui Duan, et al.
Published: (2023-06-01)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
by: Marc Miravitlles, et al.
Published: (2022-11-01)

General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study
by: A Jochmann, et al.
Published: (2010-08-01)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01)

Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
by: Anja Jochmann, et al.
Published: (2012-03-01)

Challenging case of severe acute asthma in a mechanically ventilated patient managed with sevoflurane
by: Satheesh Munusamy, et al.
Published: (2023-02-01)

Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
by: Veronika Mangold, et al.
Published: (2023-10-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Triple therapy in a single inhaler for chronic obstructive pulmonary disease: clinical studies and case report (real practice)
by: V. V. Salukhov, et al.
Published: (2021-10-01)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
by: López-Campos JL, et al.
Published: (2020-07-01)

Evaluation of medical adherence, adverse drug reactions, and quality of life in post tubercular obstructive airway disease
by: Vinita Awasthi, et al.
Published: (2023-01-01)

Newer therapeutic options in chronic obstructive pulmonary disease
by: Jesin Kumar Chakkamadathil
Published: (2023-01-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

Pharmacological Treatment in Asthma and COPD
by: Tomoaki Hoshino, et al.
Published: (2009-01-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

The adjusted impact of different severities of acute exacerbations and medications on the risk of developing dementia in COPD patients
by: Kuo-Hua Chia, et al.
Published: (2023-03-01)

Reversible Bronchial Obstruction in Primary Ciliary Dyskinesia
by: Hagit Levine, et al.
Published: (2022-11-01)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
by: Miravitlles M, et al.
Published: (2022-01-01)

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
by: Trigueros JA, et al.
Published: (2022-11-01)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
by: Lee HJ, et al.
Published: (2022-09-01)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
by: Yun Su Sim, et al.
Published: (2022-12-01)

Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study
by: Danilo Cortozi Berton, et al.

Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01)

Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance
by: D. E. O'Donnell
Published: (2006-12-01)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
by: Mario Cazzola, et al.
Published: (2023-07-01)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
by: Barbara Bonnesen, et al.
Published: (2022-06-01)

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease
by: Valladales-Restrepo LF, et al.
Published: (2023-12-01)

Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study
by: Hsiao YH, et al.
Published: (2022-09-01)

Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
by: Hashimoto S, et al.
Published: (2023-01-01)

Lung hyperinflation in COPD: the impact of pharmacotherapy
by: D. E. O'Donnell, et al.
Published: (2006-12-01)

Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
by: Cataldo D, et al.
Published: (2017-02-01)

Use of Inhaled Corticosteroids and Risk of Acquiring <i>Haemophilus influenzae</i> in Patients with Chronic Obstructive Pulmonary Disease
by: Raza Ul Mohsin, et al.
Published: (2022-06-01)

Voice changes in patients with chronic obstructive pulmonary disease
by: Enas Elsayed Mohamed, et al.
Published: (2014-07-01)

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD
by: Fukushima Y, et al.
Published: (2018-04-01)